Objective: Viral hepatitis has become a silent epidemic worldwide. The aim of the present study is to determine the knowledge and awareness of Hepatitis B infection amongst patients who refer to our clinic and their relatives.
INTRODUCTION
Hepatitis B virus (HBV) infection is an important major global public health problem.1 This global problem has long been recognized by World Health Organization (WHO).2 More than two billion people have been infected with HBV in the world. Globally, 350-400 million people suffer from chronic HBV infection.1 HBV infection has a worldwide distribution. The prevalence of HBV infection among communities shows different proportions and is associated with geographical factors.3 Distribution of HBV is classified into three groups as "low, medium and high endemic region". 4 Turkey is considered as a medium endemic region.5 HBV is 100-times more infectious than the human immunodeficiency virus (HIV). Therefore, the fight against this disease is quite important especially in terms of Anatolia region where HBV is common. 6 The most effective way to prevent HBV infections is vaccination. In Turkey, HBV vaccine has been included in the routine vaccination schedule since 1998 based on WHO recommendation. Infants at birth are vaccinated, then they are vaccinated two more times, at the end of their first month and six months.7
Health care workers are at risk for infection with bloodborne pathogens, including HBV, hepatitis C virus (HCV) and HIV. HBV has been observed in blood, saliva, semen, and other bodily secretions and fluids. HBV infection in dental professionals has been reported to be higher than the general population.8 Infections in a dental clinic can be spread via contact with blood, oral fluids, droplet splatter, aerosols, etc.9 To reduce the risk of hepatitis for dental health care providers, vaccination of the dental professionals and the patients is recommended against viral hepatitis. As individual protective pieces of equipment, dental professionals should use gloves, head caps, masks, goggles, etc.10,11 Since horizontal and vertical transmission of HBV infection could be seen in the dental clinics12 and even 4x10-5 mL of HBV-contaminated blood has been shown to cause the disease6, proper sterilization or disposable items should be used in the practice.
Horizontal transmission is often seen in endemic regions like Southeast Anatolia. Using common personal equipment and close contact with an infected person are thought to be responsible for the horizontal transmission of HBV. Horizontal infection may occur when infected objects, such as toothbrushes, razors, scissors, and manicure-pedicure sets are shared by everyone at home, at the barbershops and hairdressers. 13 The aim of the present study is to determine the knowledge and awareness of infectious diseases amongst the patients who refer to our clinic and their relatives.
MATERIALS AND METHODS

Study Design
To prevent dental workers and patients from cross infections, routine blood analysis for infectious diseases (HBsAg, Anti-HBs, Antibody to HCV (Anti-HCV), Antibody to HIV (Anti-HIV), Hepatitis A IgM antibody (Anti-HAV IgM), IgM antibody against hepatitis B core antigen (Anti-HBc IgM) and IgG antibody against hepatitis B core antigen (Anti-HBc IgG) are requested from all patients who are admitted to our clinic. 244 patients (130 women and 114 men) who were treated at the Adiyaman University Faculty of Dentistry, Department of Periodontology clinics and the test results of other family members can be reached were selected for this study (sample size is consistent with the literature). The subjects involved in the study were told the aim and the content of the study, and they signed an approval form stating that they voluntarily participated in the survey. Each individual read and signed the Helsinki Declaration before joining the study. In the first examination, the following information was obtained from the patients:
-Age -Gender -Profession -Educational level -Infectious disease status of family members -Disease awareness -HBsAg status -Anti-HBs status -Anti-HCV status -Anti-HIV status
Laboratory Testing
The serological tests are requested from all patients before the treatment seance. Blood samples were analyzed by a specialist in the Microbiology Department. HBsAg was analyzed using the AUSAB (Abbott Laboratories, Abbott Park, USA) ELISA method and anti-HBs with the AUSZYME (Abbott Laboratories, Abbott Park, USA) monoclonal ELISA method.
Patients who have natural immune response or are HBsAg (+), were informed about the disease. The contagiousness of the disease and the risk for their family members were explained to the patients. Family of HBV (+) patients were consulted by the Department of Infectious Diseases. Routine blood analysis results of other family members were also obtained for infectious diseases. Anti-HBs (-) family members were informed about vaccination.
Interpretation of hepatitis B serologic test results was determined according to 
Statistical Analysis
Statistical package program SPSS 20 (SPSS, Inc, Chicago, IL) was used for data analysis. Differences in proportions, categorical variables and means were evaluated using Chisquare and Student's T-tests, respectively.
RESULTS
We did not detect any HCV and HIV infected patients in this study. In addition, no acutely infected patient was spotted. All HBsAg (+) patients were chronically infected [IgM antiHBc (-)].
HBsAg incidence was found to be 5.7% and the proportion of the patients protected against the HBV was found to be 29.5% (Table  2) . Table 3 . Awareness of immunity due to natural infection and immunity due to Hepatitis B vaccination in anti-HBs (+) patients.
anti-HBc; Hepatitis B core antibody anti-HBs; Hepatitis B surface antibody 50% of the patients with natural immunity reported a familial history of the HBV (Table  4) . The prevalence of HBsAg (+) among patients decreased with increasing educational level. Moreover, the lowest occurrence rate of HBV infection was obtained in the health care workers group. Vaccination rate was much higher than the rate of natural immunity in the health care workers group (Table 5) . Three of the HBsAg (+) patients reported a family history of the disease (Table 6 ). Among 244 patients, 3 patients with HBsAg (+) were either not aware of their disease or did not want to disclose it. This amounts to 1.2% of the sample in the study, which is a risk factor for the society. The ratio of the patients who know that they have HBsAg (+) was 4.5% (Table7). 
DISCUSSION
Hepatitis B still remains a major global public health problem.15 This condition is related to both the continuing frequent occurrence of new infections and to the common use of objects, utensils with chronically infected person. 16 In the September 2010 report of European Centre for Disease Prevention and Control (ECDC)17, Turkey seems to have the highest number of prevalence of HBV in Europe with a prevalence of 2-8%. In Turkey, there are around 3.5 million cases, so to protect the patients and the health workers, dentists have an important role and responsibility.
According to the World Health Organization classification, Turkey has intermediate (2%-8%) endemicity for hepatitis B. This data has been obtained mainly from seroprevalence studies. Based on these studies, the overall prevalence of HBsAg positivity, which is an important parameter for chronic hepatitis B infection, has been reported to be between 4.0% and 5.0%. 18 The prevalence of anti-HBc positivity (indicating current or previous exposure to HBV infection) ranges between 26.2% and 68.8% in Turkey. 19 In the current study HBsAg (+) rate was found to be 5.7%, which is slightly higher than the reported values, and Anti HBs (+) rate was found to be 29.5%, which is within the reported values.
It was reported that the horizontal transmission is quite common in Turkey, especially in Southeast Anatolia. Horizontal transmission by non-sexual close contact is common for acute HBV infection in countries with moderate HBV region. 20 In communities with poor socioeconomic conditions, transmission between family members may occur. Therefore, in the current study, we investigated the Hepatitis status of the all other family members of patients diagnosed with chronic hepatitis B infection. Forty-seven naturally immunized patients were not aware of their immunization status and family members of a total of fifty naturally immunized patients were recommended to consult with their family physician. A familial history of hepatitis B infection was reported in 50% of the patients who have natural immunity. We directed all anti-HBs (-) family members to a specialist for vaccination. When we investigated the HBsAg (+) patients' family, three of these patients' brothers were found to have hepatitis B surface antigen. In anamnesis, we learned that they have used the same razors with their HBsAg (+) brothers. Since the number of family member who lives at the same house is high in Turkey, and pieces of equipment such as toothbrushes, razors, scissors, and manicure-pedicure sets are shared by everyone at home, the transmission of the virus between family members could be related to the use of common utensils and tools.20 Physicians and dentists have an obligation to warn the people who are admitted to their clinics about these bloodborne infections. We directed all family members of HBsAg (+) patients to a family physician for vaccination and preventive care.
Hepatitis B is an important occupational risk for health care workers.1-3 In some studies, health care workers have been shown to have an up to four-fold increased risk of acquiring HBV infection.22,23 Although health care providers are believed to be at higher risk for acquiring bloodborne viral infections compared to the general population, the lowest occurrence of HBsAg (+) was found in health care workers and educationalist groups, which suggests that rate of HBsAg (+) individuals decreases with increasing education. Preventive vaccination against hepatitis B for health care providers is a standard practice in many countries like Turkey.24,25 Thus, vaccination rate was found to be also higher than the rate of natural immunity in the health care worker group, which could be related to the awareness of the disease among this group in our study.
In this study, three patients with HBsAg (+) who were not aware of their disease were found. This amounts to 1.2% of the sample in the study which is a risk factor for our society. When the patients apply to our clinic, dentists should consult a specialist before the treatments in order to decrease the bloodborne infections risk.
WHO's primary goal on Hepatitis is to further reduce the global mortality and morbidity related to viral hepatitis.1-3 The global control of viral hepatitis infection remains one of the major missions that need to be continued in this century. 16 Knowledge and approach of the dentists play a key role in prevention of spread of these bloodborne infections. 26 In Turkey, HBV infection is generally spread horizontally but vertical spreading is also significant.13 In our clinic, we want to raise awareness of these infectious diseases, because awareness and knowledge are important for protection from diseases.
The shortcoming of this study is the smallness of the sample size: more specifically, the number of family members that we were able to reach could be larger for better results. Another drawback is that we studied the family members of only two types of patients with HBsAg (+) and Anti-HBs (+), which should be extended to HBsAg (-) and anti-HBs (-).
CONCLUSIONS
Hepatitis is a serious global public health problem that affects more than two billion people, constituting a problem that concerns everyone in the society. Dentists hold especially great responsibility for the prevention and handling of this problem. In short, the aim of this study was to increase vaccination rate and preventive care among our patients and their families and to increase the early detection rate of bloodborne infectious diseases. On the other hand, improvement of the recording system of the patients and general increase of awareness about these infectious diseases are the other goals of this current study.
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